You are invited to take part in a research study. Before you decide whether or not to take part, it is important to understand what the study is about and what it will involve. Please read this information and if you have any questions, please contact the person named at the end. Your participation is important to us but is entirely voluntary.
Background
As we learn more about COVID-19 and are better able to support people, it has become clear that many people experience long term symptoms relating to a COVID-19 infection (Long COVID). This is a challenge for healthcare. Traditionally, care pathways for long-term conditions are focused on single diseases; however, that approach is not effective at supporting people with more than one long-term condition or those with medically not yet explained symptoms. Long COVID usually presents with clusters of symptoms, which may change over time. Therefore, healthcare services have to take a broader approach to care focusing on more than one system (biological, psychological and social which together are called a biopsychosocial approach). This is called an integrated care pathway. Integrated care means more than patient-centred care which can be provided in one setting, integrated care involves the whole pathway from primary care to specialist services and rehabilitation services.
In the UK, integrated care pathways offer an opportunity to explore the benefits of an integrated approach to care for long COVID, long-term conditions and multiple long-term conditions. This Delphi study refers to the approaches for considering transferability of present long COVID integrated care pathway care models to other long-term conditions.
This study seeks to answer the broad research question: What are effective integrated care pathways for individuals with long COVID and how can they be transferred to other long-term conditions including mental health problems, multple long-term conditions and the interface between known medical disorders and medically not yet explained symptoms as well as newly developed conditions?
This Delphi study using a biopsychosocial approach, will investigate:
1. (a) Key enabling elements for effective integrated care pathways for individuals with long COVID, based on user experience, and (b) Strengths of existing integrated care pathways for other long-term conditions.
2. Which (part of an) integrated care pathway model for long COVID can be transferred to other long-term conditions for which care pathways were not yet developed sufficiently, and how.
3. Variations in uptake and adherence to treatment in long COVID and long-term conditions.
Who is doing the study?
This study is being led by Prof. Christina Van Der Feltz-Cornelis, Department of Health Sciences, University of York, UK. The study is part of the STIMULATE-ICP research (
https://www.stimulate-icp.org/) and is funded by the National Institute of Health Research (NIHR), UK.